Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children

Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs

(2010) Elaine H. Morrato et al.   ARCHIVES OF GENERAL PSYCHIATRY

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder

(2009) Melissa P DelBello et al.   BIPOLAR DISORDERS

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study

(2009) Magali Haas et al.   BIPOLAR DISORDERS

Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study

(2009) Magali Haas et al.   BRITISH JOURNAL OF PSYCHIATRY

Depressive symptoms and the metabolic syndrome in childhood and adulthood: A prospective cohort study.

(2009) Laura Pulkki-Råback et al.   HEALTH PSYCHOLOGY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia

(2009) Magali Haas et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Aripiprazole in Children and Adolescents With Bipolar Disorder Comorbid With Attention-Deficit/Hyperactivity Disorder

(2009) Silzá Tramontina et al.   JOURNAL OF CLINICAL PSYCHIATRY

Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole

(2009) Robert L. Findling et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

(2009) R. Owen et al.   PEDIATRICS

Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study

(2008) Linmarie Sikich et al.   AMERICAN JOURNAL OF PSYCHIATRY

Childhood predictors of the metabolic syndrome in adulthood. The Cardiovascular Risk in Young Finns Study

(2008) Noora Mattsson et al.   ANNALS OF MEDICINE

Extrapyramidal side-effects of antipsychotics in a randomised trial

(2008) Del D. Miller et al.   BRITISH JOURNAL OF PSYCHIATRY

Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Ludmila Kryzhanovskaya et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Clozapine and “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: A 12-Week Randomized and Double-Blind Comparison

(2007) Sanjiv Kumra et al.   BIOLOGICAL PSYCHIATRY

Randomized Controlled Pilot Study of Quetiapine in the Treatment of Adolescent Conduct Disorder

(2007) Daniel F. Connor et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY